Several of us here at UC Davis and other Northern California institutions have worked together to organize a unique symposium on CRISPR and genetic modification. You are invited to attend the free meeting, which will take place on May 26th. You can register here. We will cover CRISPR ethics, policy, and law as they relate both […]
Invitation to attend novel CRISPR ethics & policy symposium Read More »
Remember that CRISPR patent battle? Who really invented CRISPR? If it was many people and labs, who did it first and who deserves the credit? When things like Nobel Prizes and Patents get decided on CRISPR-Cas9, who will be for lack of a better way of putting it, the winners and the losers? It’s not
A hunch on that CRISPR patent battle as it heats up Read More »
It’s exciting that the reviews are starting to come in on my new book, GMO Sapiens, on human genetic modification including CRISPR. Here is one from The Scientist and the book was recommended by Scientific American. Reviews from individual authors and scientists are below. “GMO Sapiens could not be more timely. New technologies like CRISPR-Cas9 gene
Reviews of my new book GMO Sapiens on #CRISPR & human modification Read More »
New genetic modification technology such as CRISPR-Cas9 has opened the door to transformative biological research, but it has also set the table for some novel kinds of technological problems for which we aren’t at all prepared including one that I call the “gene spill”. The striking potential upsides to CRISPR paired with some of the
A new possible environmental disaster: the gene spill Read More »
Clinical research on Type I Diabetes is one of the most exciting and promising areas of stem cells and regenerative medicine for human disease. Two of the coolest companies out there in this arena have been ViaCyte and BetaLogics (owned by J&J). For more on ViaCyte see my interview with President and CEO Paul Laikind
ViaCyte on the Rise: First Diabetes Trial Data & Acquires BetaLogics IP Read More »
Politicians including Trump may start talking about CRISPR more and more in the near future. What if politicians weighed in on CRISPR with Tweets or statements in debates? What if this happened during the particularly charged time of a political campaign such as now? Below is a Saturday science satire in that spirit of imagined Tweets
If Trump & Other Politicians Debated #CRISPR: Saturday Science Satire Read More »
The patent dispute on CRISPR between UC/Jennifer Doudna and The Broad/Feng Zhang has been the subject of major attention including in a recent piece on Stanford Center for Law & Biosciences Blog. There is a lot of confusion over this important CRISPR dispute so I turned to a patent expert for their take on this via an interview
Patent expert weighs in on CRISPR dispute between UC & Broad Read More »
Happy Martin Luther King Jr. Day. In December I attended and spoke at the World Stem Cell Summit in Atlanta. It was a great meeting, but also I had the chance to go visit the Martin Luther King (MLK) Monument and tour his birth home. It was a very inspirational experience. MLK has been a hero
Inspirational visit to MLK birth home Read More »
Science blogging is somewhat of a communal exercise. At least, it should be and cool biomed blogs are a great community. One of the most invigorating aspects of blogging is finding new blogs that are worthwhile and edgy. Below I list some of my recommendations for blogs that you might not be familiar with, but
Cool biomed blogs you may not heard of: a drugmonkey, a med student, #CRISPR, & more Read More »
Over at RetractionWatch, their team does a great job following retractions of science papers. Sadly, the number of published manuscript retractions gives them more than enough material to post several times a day. There’s another phenomenon going on that I think might warrant their increased attention: the possibly rising number of retractions or corrections of science
Science press releases behaving badly: time to start tracking their retractions? Read More »